Preemptive therapy in nonneutropenic patients with Candida infection using the Japanese Guidelines

Annals of Pharmacotherapy

Volumn 41, Issue 7-8, 2007, Pages 1137-1143

  Tsuruta, Ryosuke ^a   Mizuno, Hidekazu ^a   Kaneko, Tadashi ^a   Oda, Yasutaka ^a   Kaneda, Kotaro ^a   Fujita, Motoki ^a   Inoue, Takeshi ^b   Kasaoka, Shunji ^b   Maekawa, Tsuyoshi ^b  

^a YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

D glucan test; Candida infections; Guidelines

Indexed keywords

ANTIFUNGAL AGENT; BETA GLUCAN; FLUCONAZOLE; MICAFUNGIN; MICONAZOLE;

ADULT; AGE DISTRIBUTION; APACHE; ARTICLE; CANDIDA; CANDIDIASIS; FEMALE; HEMODIAFILTRATION; HUMAN; INTENSIVE CARE UNIT; JAPANESE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SEX RATIO; VENTILATED PATIENT;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FEMALE; HUMANS; INTENSIVE CARE UNITS; JAPAN; MALE; MIDDLE AGED; NEUTROPENIA; PRACTICE GUIDELINES;

EID: 34547191648     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K010     Document Type: Article

References (32)

1. Vincent J-L, Anaissie E, Bruining H, et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998;24:206-16.
2. Berenguer J, Buck M, Witebsky F, et al. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis 1993;17:103-9.
3. Garbino J, Lew DP, Romand JA, et al. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 2002;28:1708-17.
4. Ostrosky-Zeicher L. Prophylaxis and treatment of invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2004;23:739-44.
5. Pittet D, Monod M, Suter PM, et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-8.
6. León C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006;34:730-7.
7. Eggimann P, Garbino J, Pittet D. Management of Candida species infections in critically ill patients. Lancet Infect Dis 2003;3:772-85.
8. Rex JH, Walsh TJ, Sobel JD, et al. Practical guidelines for the treatments of candidiasis. Clin Infect Dis 2000;30:662-78.
9. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004;38:161-89.
10. Deep-seated mycosis guidelines editorial committee: guidelines for the diagnosis and treatment of deep-seated mycosis [Japanese]. Tokyo, Ishiyaku: 2003.
11. Yoshida M. Guidelines for the management of deep mycosis in neutropenic patients. Jpn J Med Mycol 2004;45:209-15.
12. Aikawa N, Kohno S, Shibuya K, et al. Current status of diagnosis and treatment of invasive fungal infections in Japan: the influence of the new Japanese guidelines. J Infect Chemother 2005;11:278-87.
13. Obayashi T, Yoshida M, Mori T, et al. Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995;345:17-20.
14. Mori T, Ikemoto H, Matsumura M, et al. Evaluation of plasma (1→3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infection. Eur J Clin Chem Clin Biochem 1997;35:553-60.
15. Takesue Y, Kakehashi M, Ohge H, et al. Combined assessment of β-D-glucan and degree of Candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg 2004;28:625-30.
16. British Society for Antimicrobial Chemotherapy working party. Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 1994;20:522-8.
17. Yoshida K, Niki Y, Mitekura H, et al. A discrepancy in the value of serum (1→3)-β-D-glucan measured by two kits using different methods. Jpn J Med Mycol 2001;42:243-51.
18. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and multiple organ failure. Crit Care Med 1992;20:864-74.
19. Kanda H, Kubo K, Hamasaki K, et al. Influence of various hemodialysis membranes on the plasma (1→3)-β-D-glucan level. Kidney Int 2001;60:319-23.
20. Ohta T, Kikuchi H, Hashi K, et al. Nizofenone administration in the acute stage following subarachnoid hemorrhage. Results of a multi-center controlled double-blind clinical study. J Neurosurg 1986;64:420-6.
21. Tobiasen J, Hiebert JH, Edlich RF. Prediction of burn mortality. Surg Gynecol Obstet 1982;154:711-4.
22. Baker SP, O'Neill B, Haddon W, et al. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974;14:187-96.
23. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
24. Blot SI, Vandewoude KH, Hoste EA, et al. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002;113:480-5.
25. Nolla-Salas J, Sitges-Serra A, León-Gil C, et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Intensive Care Med 1997;23:23-30.
26. Leleu G, Aegerter P, Guidet B, et al. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 2002;17:168-75.
27. Rangel-Frausto MS, Wiblin T, Blumberg HM, et al. National epidemiology of mycoses (NEMIS): variation in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999;29:253-8.
28. Vardakas KZ, Samonis G, Michalopulos A, et al. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med 2006;34:1216-24.
29. Shorr AF, Chung K, Jackson WL, et al. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med 2005;33:1928-35.
30. Garrelts JC, Schroeder TR, Harrison PB. Impact of fluconazole administration on outcomes in critically ill patients. Ann Pharmacother 2004;38:1588-92. Epub 31 Aug 2004. DOI 10.1345/aph.1D441
31. Piarroux R, Grenouillet F, Balvay P, et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 2004;32:2443-9.
32. Pelz RK, Hendrix CW, Swoboda SM, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001;233:542-8.